Actively Recruiting
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
Led by Endeavor Health · Updated on 2025-03-27
1725
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying postpartum hemorrhage, which is excessive bleeding after delivery and affects up to 5% of patients in the United States. This study focuses on hemorrhages that happen in the medium term, specifically between 1.5 to 24 hours after birth. The goal is to see if ultrasound exams done early in this period, about 1.5 to 2 hours after delivery, can identify signs that predict medium-term bleeding. This research collects detailed medical and obstetrical history, labor and delivery outcomes, and information about postpartum bleeding. Participants will receive a postpartum ultrasound exam focusing on uterine measurements, the endometrial stripe, fibroids, vagina, and bladder within 1.5 to 2 hours after delivery. This observational study does not involve any drug or treatment but monitors patients closely with ultrasound imaging. Data collection extends through the delivery admission and may include hospital readmission information up to 6 weeks postpartum. Throughout the study, participants will provide medical history and delivery details, with researchers reviewing ultrasound results and postpartum charts. The main measurements involve ultrasound findings shortly after birth. If a participant is readmitted to the hospital after discharge, their records may be reviewed up to 6 weeks postpartum. Participation begins as early as a prenatal visit after 36 weeks or during delivery admission, lasting until the postpartum period ends.
CONDITIONS
Brief Title
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Currently pregnant and planning to deliver at Endeavor Health at 37 weeks gestational age or later
- English speaking
- Labor less than 6cm dilated at time of consent without epidural
- Labor less than 8cm dilated at time of consent with epidural
You will not qualify if you...
- Preterm delivery
- Non-English speaking
- Any conditions that impair potential participants' decision making
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 hours post delivery
Participants undergo postpartum ultrasound exams to assess uterine and pelvic structures shortly after delivery.
1 visit (in-person)
Duration - 6 weeks post delivery
Participants' medical charts are reviewed to monitor outcomes up to 6 weeks after delivery.
No additional visits; chart review only
Trial Site Locations
Total: 1 location
1
Endeavor Health
Evanston, Illinois, United States, 60201
Actively Recruiting
Research Team
K
Kate Honeyfield
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here